FDA Inspection
Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site)Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) – FDA Inspection, Jan 13, 2023
Record Details
This FDA Inspection record concerns Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site), with an inspection on January 13, 2023, issued by the Office of Inspections and Investigations.
- Inspection Date
- January 13, 2023
View Company Profile
ID · b7268b41-7f73-4392-9cd1-8583ae23caf6
Inspection Facts
- Inspection number
- 1195951
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site)
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2025 | Not classified | Office of Inspections and Investigations |
Other documents for Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site)
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.